Lifevantage Corp (LFVN) income statement
LFVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 20/3044% below fair value
$4.81+0.03 (+0.63%)
Close on Nov 18, 2026Market cap $60.26MP/E 12.0Yield 3.85%
Lifevantage Corp income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 77.6%
- Operating margin
- 3.3%
- Net margin
- 2.8%
- Return on equity, FY2026
- 14.9%
Financial strength
- Current ratio
- 1.89
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 73.8%
Valuation
- P/E ratio
- 12.0
- Price to sales
- 0.33
- Price to book
- 1.79
- Dividend yield
- 3.85%
See a number that looks wrong?